Global Sleep Aid Device Market
Global Sleep Aid Device Market

Sleep Aid Device Comprehensive Study by Type (Mattress and pillows, Sleep laboratory services, Medication, Sleep apnea devices, Others), Distribution Channel (Retail Stores, Online Sales), Disorders (Insomnia, Sleep Apnea, Restless Legs Syndrome, Narcolepsy, Sleep Walking, Other Sleep Disorders) Players and Region - Global Market Outlook to 2024

Sleep Aid Device Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Jan 2019 Edition 211 Pages 170 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Sleep Aid Device Market Overview:
Sleep Aid Device is known as the devices which can provide solutions to an individual’s sleeping disorder. Seeping aids device ensure the treatment and diagnosis for the sleep disturbances and disorders. The symptoms of sleep disorders normally include daytime sleepiness, irregular breathing and behaviours of abnormal sleeping and increasing movements during sleep. Sleep disorders has an very adverse effect to the human health. It can cause neural problems that can lead to the accidents, lower the productivity of work done by an individual and can also cause stress and depression. Moreover, sleep disorder can lead to some major chronic diseases like as cardiovascular diseases, obesity and diabetes Some of the key players profiled in the study are Koninklijke Philips N.V. (Netherlands), Merck & Co. (United States), Sanofi (France), DeVilbiss Healthcare LLC. (United States), Pfizer Inc. (United States), SleepMed Inc. (United States), Cadwell Laboratories Inc (United States), Compumedics Limited (Australia), Natus Medical Incorporated (United States) and GlaxoSmithKline plc (United Kingdom).

On the basis of geography, the market of Sleep Aid Device has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Distribution Channel, the sub-segment i.e. Retail Stores will boost the Sleep Aid Device market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Disorders, the sub-segment i.e. Insomnia will boost the Sleep Aid Device market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Growing healthcare facilities,
  • Surge in the demand for sleeping pills attributed to stressful modern lifestyle

Market Trend
  • Advancement in technology related to sleeping AID device

Restraints
  • Adverse effects of sleep aid medication
  • Patent expiration

Opportunities
  • Technological advancements leading to better adoption
  • Untapped markets in developing economies

Challenges
  • High cost associated with some of the sleeping AID devices


Major Market Developments:

Drive Medical Acquires DeVilbiss Healthcare, Creating a Worldwide Leader in Respiratory, Sleep and Durable Medical Products
Merck, known as MSD outside the United States and Canada, announced the first presentation of results from KEYNOTE-181, a Phase 3 trial investigating KEYTRUDA, Merck’s anti-PD-1 therapy, as monotherapy for the second-line treatment of advanced or metastatic esophageal or esophagogastric junction carcinoma

Target Audience:
Sleep Aid Device manufacturers, Sleep Aid Device and raw material suppliers, Sleep Aid Device providers, Sleep Aid Device wholesalers and retailers, Research firm, Regulatory bodies, Healthcare centres and End users

Major Objectives Focused through this Study
• To define, describe, and forecast the Global Sleep Aid Device market on the basis of product [Mattress and pillows, Sleep laboratory services, Medication, Sleep apnea devices and Others] , application [], key regions and end user
• To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
• To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
• Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
• To provide market size for various segments of the Sleep Aid Device market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
• To strategically profile the key players and analyzing their market shares and core competencies in the Sleep Aid Device industry
• To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are Teva Pharmaceutical Industries Ltd. (Israel), Takeda Pharmaceutical Company Limited (Japan), CareFusion Corporation (United States) and Drive Medical Ltd. (United Kingdom).
** Confirmation on availability of data would be informed prior purchase

While framing the research framework, major and emerging players operating in the Sleep Aid Device market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.
Report Objectives / Segmentation Covered
By Type
  • Mattress and pillows
  • Sleep laboratory services
  • Medication
  • Sleep apnea devices
  • Others
By Distribution Channel
  • Retail Stores
  • Online Sales

By Disorders
  • Insomnia
  • Sleep Apnea
  • Restless Legs Syndrome
  • Narcolepsy
  • Sleep Walking
  • Other Sleep Disorders

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing healthcare facilities,
      • 3.2.2. Surge in the demand for sleeping pills attributed to stressful modern lifestyle
    • 3.3. Market Challenges
      • 3.3.1. High cost associated with some of the sleeping AID devices
    • 3.4. Market Trends
      • 3.4.1. Advancement in technology related to sleeping AID device
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Sleep Aid Device, by Type, Distribution Channel, Disorders and Region (value) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Sleep Aid Device (Value)
      • 5.2.1. Global Sleep Aid Device by: Type (Value)
        • 5.2.1.1. Mattress and pillows
        • 5.2.1.2. Sleep laboratory services
        • 5.2.1.3. Medication
        • 5.2.1.4. Sleep apnea devices
        • 5.2.1.5. Others
      • 5.2.2. Global Sleep Aid Device by: Distribution Channel (Value)
        • 5.2.2.1. Retail Stores
        • 5.2.2.2. Online Sales
      • 5.2.3. Global Sleep Aid Device by: Disorders (Value)
        • 5.2.3.1. Insomnia
        • 5.2.3.2. Sleep Apnea
        • 5.2.3.3. Restless Legs Syndrome
        • 5.2.3.4. Narcolepsy
        • 5.2.3.5. Sleep Walking
        • 5.2.3.6. Other Sleep Disorders
      • 5.2.4. Global Sleep Aid Device Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Sleep Aid Device: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Koninklijke Philips N.V. (Netherlands)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Merck & Co. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Sanofi (France)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. DeVilbiss Healthcare LLC. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Pfizer Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. SleepMed Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Cadwell Laboratories Inc (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Compumedics Limited (Australia)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Natus Medical Incorporated (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. GlaxoSmithKline plc (United Kingdom)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Sleep Aid Device Sale, by Type, Distribution Channel, Disorders and Region (value) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Sleep Aid Device (Value)
      • 7.2.1. Global Sleep Aid Device by: Type (Value)
        • 7.2.1.1. Mattress and pillows
        • 7.2.1.2. Sleep laboratory services
        • 7.2.1.3. Medication
        • 7.2.1.4. Sleep apnea devices
        • 7.2.1.5. Others
      • 7.2.2. Global Sleep Aid Device by: Distribution Channel (Value)
        • 7.2.2.1. Retail Stores
        • 7.2.2.2. Online Sales
      • 7.2.3. Global Sleep Aid Device by: Disorders (Value)
        • 7.2.3.1. Insomnia
        • 7.2.3.2. Sleep Apnea
        • 7.2.3.3. Restless Legs Syndrome
        • 7.2.3.4. Narcolepsy
        • 7.2.3.5. Sleep Walking
        • 7.2.3.6. Other Sleep Disorders
      • 7.2.4. Global Sleep Aid Device Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Sleep Aid Device: by Type(USD Million)
  • Table 2. Sleep Aid Device Mattress and pillows , by Region USD Million (2013-2018)
  • Table 3. Sleep Aid Device Sleep laboratory services , by Region USD Million (2013-2018)
  • Table 4. Sleep Aid Device Medication , by Region USD Million (2013-2018)
  • Table 5. Sleep Aid Device Sleep apnea devices , by Region USD Million (2013-2018)
  • Table 6. Sleep Aid Device Others , by Region USD Million (2013-2018)
  • Table 7. Sleep Aid Device: by Distribution Channel(USD Million)
  • Table 8. Sleep Aid Device Retail Stores , by Region USD Million (2013-2018)
  • Table 9. Sleep Aid Device Online Sales , by Region USD Million (2013-2018)
  • Table 10. Sleep Aid Device: by Disorders(USD Million)
  • Table 11. Sleep Aid Device Insomnia , by Region USD Million (2013-2018)
  • Table 12. Sleep Aid Device Sleep Apnea , by Region USD Million (2013-2018)
  • Table 13. Sleep Aid Device Restless Legs Syndrome , by Region USD Million (2013-2018)
  • Table 14. Sleep Aid Device Narcolepsy , by Region USD Million (2013-2018)
  • Table 15. Sleep Aid Device Sleep Walking , by Region USD Million (2013-2018)
  • Table 16. Sleep Aid Device Other Sleep Disorders , by Region USD Million (2013-2018)
  • Table 17. South America Sleep Aid Device, by Country USD Million (2013-2018)
  • Table 18. South America Sleep Aid Device, by Type USD Million (2013-2018)
  • Table 19. South America Sleep Aid Device, by Distribution Channel USD Million (2013-2018)
  • Table 20. South America Sleep Aid Device, by Disorders USD Million (2013-2018)
  • Table 21. Brazil Sleep Aid Device, by Type USD Million (2013-2018)
  • Table 22. Brazil Sleep Aid Device, by Distribution Channel USD Million (2013-2018)
  • Table 23. Brazil Sleep Aid Device, by Disorders USD Million (2013-2018)
  • Table 24. Argentina Sleep Aid Device, by Type USD Million (2013-2018)
  • Table 25. Argentina Sleep Aid Device, by Distribution Channel USD Million (2013-2018)
  • Table 26. Argentina Sleep Aid Device, by Disorders USD Million (2013-2018)
  • Table 27. Rest of South America Sleep Aid Device, by Type USD Million (2013-2018)
  • Table 28. Rest of South America Sleep Aid Device, by Distribution Channel USD Million (2013-2018)
  • Table 29. Rest of South America Sleep Aid Device, by Disorders USD Million (2013-2018)
  • Table 30. Asia Pacific Sleep Aid Device, by Country USD Million (2013-2018)
  • Table 31. Asia Pacific Sleep Aid Device, by Type USD Million (2013-2018)
  • Table 32. Asia Pacific Sleep Aid Device, by Distribution Channel USD Million (2013-2018)
  • Table 33. Asia Pacific Sleep Aid Device, by Disorders USD Million (2013-2018)
  • Table 34. China Sleep Aid Device, by Type USD Million (2013-2018)
  • Table 35. China Sleep Aid Device, by Distribution Channel USD Million (2013-2018)
  • Table 36. China Sleep Aid Device, by Disorders USD Million (2013-2018)
  • Table 37. Japan Sleep Aid Device, by Type USD Million (2013-2018)
  • Table 38. Japan Sleep Aid Device, by Distribution Channel USD Million (2013-2018)
  • Table 39. Japan Sleep Aid Device, by Disorders USD Million (2013-2018)
  • Table 40. India Sleep Aid Device, by Type USD Million (2013-2018)
  • Table 41. India Sleep Aid Device, by Distribution Channel USD Million (2013-2018)
  • Table 42. India Sleep Aid Device, by Disorders USD Million (2013-2018)
  • Table 43. South Korea Sleep Aid Device, by Type USD Million (2013-2018)
  • Table 44. South Korea Sleep Aid Device, by Distribution Channel USD Million (2013-2018)
  • Table 45. South Korea Sleep Aid Device, by Disorders USD Million (2013-2018)
  • Table 46. Taiwan Sleep Aid Device, by Type USD Million (2013-2018)
  • Table 47. Taiwan Sleep Aid Device, by Distribution Channel USD Million (2013-2018)
  • Table 48. Taiwan Sleep Aid Device, by Disorders USD Million (2013-2018)
  • Table 49. Australia Sleep Aid Device, by Type USD Million (2013-2018)
  • Table 50. Australia Sleep Aid Device, by Distribution Channel USD Million (2013-2018)
  • Table 51. Australia Sleep Aid Device, by Disorders USD Million (2013-2018)
  • Table 52. Rest of Asia-Pacific Sleep Aid Device, by Type USD Million (2013-2018)
  • Table 53. Rest of Asia-Pacific Sleep Aid Device, by Distribution Channel USD Million (2013-2018)
  • Table 54. Rest of Asia-Pacific Sleep Aid Device, by Disorders USD Million (2013-2018)
  • Table 55. Europe Sleep Aid Device, by Country USD Million (2013-2018)
  • Table 56. Europe Sleep Aid Device, by Type USD Million (2013-2018)
  • Table 57. Europe Sleep Aid Device, by Distribution Channel USD Million (2013-2018)
  • Table 58. Europe Sleep Aid Device, by Disorders USD Million (2013-2018)
  • Table 59. Germany Sleep Aid Device, by Type USD Million (2013-2018)
  • Table 60. Germany Sleep Aid Device, by Distribution Channel USD Million (2013-2018)
  • Table 61. Germany Sleep Aid Device, by Disorders USD Million (2013-2018)
  • Table 62. France Sleep Aid Device, by Type USD Million (2013-2018)
  • Table 63. France Sleep Aid Device, by Distribution Channel USD Million (2013-2018)
  • Table 64. France Sleep Aid Device, by Disorders USD Million (2013-2018)
  • Table 65. Italy Sleep Aid Device, by Type USD Million (2013-2018)
  • Table 66. Italy Sleep Aid Device, by Distribution Channel USD Million (2013-2018)
  • Table 67. Italy Sleep Aid Device, by Disorders USD Million (2013-2018)
  • Table 68. United Kingdom Sleep Aid Device, by Type USD Million (2013-2018)
  • Table 69. United Kingdom Sleep Aid Device, by Distribution Channel USD Million (2013-2018)
  • Table 70. United Kingdom Sleep Aid Device, by Disorders USD Million (2013-2018)
  • Table 71. Netherlands Sleep Aid Device, by Type USD Million (2013-2018)
  • Table 72. Netherlands Sleep Aid Device, by Distribution Channel USD Million (2013-2018)
  • Table 73. Netherlands Sleep Aid Device, by Disorders USD Million (2013-2018)
  • Table 74. Rest of Europe Sleep Aid Device, by Type USD Million (2013-2018)
  • Table 75. Rest of Europe Sleep Aid Device, by Distribution Channel USD Million (2013-2018)
  • Table 76. Rest of Europe Sleep Aid Device, by Disorders USD Million (2013-2018)
  • Table 77. MEA Sleep Aid Device, by Country USD Million (2013-2018)
  • Table 78. MEA Sleep Aid Device, by Type USD Million (2013-2018)
  • Table 79. MEA Sleep Aid Device, by Distribution Channel USD Million (2013-2018)
  • Table 80. MEA Sleep Aid Device, by Disorders USD Million (2013-2018)
  • Table 81. Middle East Sleep Aid Device, by Type USD Million (2013-2018)
  • Table 82. Middle East Sleep Aid Device, by Distribution Channel USD Million (2013-2018)
  • Table 83. Middle East Sleep Aid Device, by Disorders USD Million (2013-2018)
  • Table 84. Africa Sleep Aid Device, by Type USD Million (2013-2018)
  • Table 85. Africa Sleep Aid Device, by Distribution Channel USD Million (2013-2018)
  • Table 86. Africa Sleep Aid Device, by Disorders USD Million (2013-2018)
  • Table 87. North America Sleep Aid Device, by Country USD Million (2013-2018)
  • Table 88. North America Sleep Aid Device, by Type USD Million (2013-2018)
  • Table 89. North America Sleep Aid Device, by Distribution Channel USD Million (2013-2018)
  • Table 90. North America Sleep Aid Device, by Disorders USD Million (2013-2018)
  • Table 91. United States Sleep Aid Device, by Type USD Million (2013-2018)
  • Table 92. United States Sleep Aid Device, by Distribution Channel USD Million (2013-2018)
  • Table 93. United States Sleep Aid Device, by Disorders USD Million (2013-2018)
  • Table 94. Canada Sleep Aid Device, by Type USD Million (2013-2018)
  • Table 95. Canada Sleep Aid Device, by Distribution Channel USD Million (2013-2018)
  • Table 96. Canada Sleep Aid Device, by Disorders USD Million (2013-2018)
  • Table 97. Mexico Sleep Aid Device, by Type USD Million (2013-2018)
  • Table 98. Mexico Sleep Aid Device, by Distribution Channel USD Million (2013-2018)
  • Table 99. Mexico Sleep Aid Device, by Disorders USD Million (2013-2018)
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Sleep Aid Device: by Type(USD Million)
  • Table 111. Sleep Aid Device Mattress and pillows , by Region USD Million (2019-2024)
  • Table 112. Sleep Aid Device Sleep laboratory services , by Region USD Million (2019-2024)
  • Table 113. Sleep Aid Device Medication , by Region USD Million (2019-2024)
  • Table 114. Sleep Aid Device Sleep apnea devices , by Region USD Million (2019-2024)
  • Table 115. Sleep Aid Device Others , by Region USD Million (2019-2024)
  • Table 116. Sleep Aid Device: by Distribution Channel(USD Million)
  • Table 117. Sleep Aid Device Retail Stores , by Region USD Million (2019-2024)
  • Table 118. Sleep Aid Device Online Sales , by Region USD Million (2019-2024)
  • Table 119. Sleep Aid Device: by Disorders(USD Million)
  • Table 120. Sleep Aid Device Insomnia , by Region USD Million (2019-2024)
  • Table 121. Sleep Aid Device Sleep Apnea , by Region USD Million (2019-2024)
  • Table 122. Sleep Aid Device Restless Legs Syndrome , by Region USD Million (2019-2024)
  • Table 123. Sleep Aid Device Narcolepsy , by Region USD Million (2019-2024)
  • Table 124. Sleep Aid Device Sleep Walking , by Region USD Million (2019-2024)
  • Table 125. Sleep Aid Device Other Sleep Disorders , by Region USD Million (2019-2024)
  • Table 126. South America Sleep Aid Device, by Country USD Million (2019-2024)
  • Table 127. South America Sleep Aid Device, by Type USD Million (2019-2024)
  • Table 128. South America Sleep Aid Device, by Distribution Channel USD Million (2019-2024)
  • Table 129. South America Sleep Aid Device, by Disorders USD Million (2019-2024)
  • Table 130. Brazil Sleep Aid Device, by Type USD Million (2019-2024)
  • Table 131. Brazil Sleep Aid Device, by Distribution Channel USD Million (2019-2024)
  • Table 132. Brazil Sleep Aid Device, by Disorders USD Million (2019-2024)
  • Table 133. Argentina Sleep Aid Device, by Type USD Million (2019-2024)
  • Table 134. Argentina Sleep Aid Device, by Distribution Channel USD Million (2019-2024)
  • Table 135. Argentina Sleep Aid Device, by Disorders USD Million (2019-2024)
  • Table 136. Rest of South America Sleep Aid Device, by Type USD Million (2019-2024)
  • Table 137. Rest of South America Sleep Aid Device, by Distribution Channel USD Million (2019-2024)
  • Table 138. Rest of South America Sleep Aid Device, by Disorders USD Million (2019-2024)
  • Table 139. Asia Pacific Sleep Aid Device, by Country USD Million (2019-2024)
  • Table 140. Asia Pacific Sleep Aid Device, by Type USD Million (2019-2024)
  • Table 141. Asia Pacific Sleep Aid Device, by Distribution Channel USD Million (2019-2024)
  • Table 142. Asia Pacific Sleep Aid Device, by Disorders USD Million (2019-2024)
  • Table 143. China Sleep Aid Device, by Type USD Million (2019-2024)
  • Table 144. China Sleep Aid Device, by Distribution Channel USD Million (2019-2024)
  • Table 145. China Sleep Aid Device, by Disorders USD Million (2019-2024)
  • Table 146. Japan Sleep Aid Device, by Type USD Million (2019-2024)
  • Table 147. Japan Sleep Aid Device, by Distribution Channel USD Million (2019-2024)
  • Table 148. Japan Sleep Aid Device, by Disorders USD Million (2019-2024)
  • Table 149. India Sleep Aid Device, by Type USD Million (2019-2024)
  • Table 150. India Sleep Aid Device, by Distribution Channel USD Million (2019-2024)
  • Table 151. India Sleep Aid Device, by Disorders USD Million (2019-2024)
  • Table 152. South Korea Sleep Aid Device, by Type USD Million (2019-2024)
  • Table 153. South Korea Sleep Aid Device, by Distribution Channel USD Million (2019-2024)
  • Table 154. South Korea Sleep Aid Device, by Disorders USD Million (2019-2024)
  • Table 155. Taiwan Sleep Aid Device, by Type USD Million (2019-2024)
  • Table 156. Taiwan Sleep Aid Device, by Distribution Channel USD Million (2019-2024)
  • Table 157. Taiwan Sleep Aid Device, by Disorders USD Million (2019-2024)
  • Table 158. Australia Sleep Aid Device, by Type USD Million (2019-2024)
  • Table 159. Australia Sleep Aid Device, by Distribution Channel USD Million (2019-2024)
  • Table 160. Australia Sleep Aid Device, by Disorders USD Million (2019-2024)
  • Table 161. Rest of Asia-Pacific Sleep Aid Device, by Type USD Million (2019-2024)
  • Table 162. Rest of Asia-Pacific Sleep Aid Device, by Distribution Channel USD Million (2019-2024)
  • Table 163. Rest of Asia-Pacific Sleep Aid Device, by Disorders USD Million (2019-2024)
  • Table 164. Europe Sleep Aid Device, by Country USD Million (2019-2024)
  • Table 165. Europe Sleep Aid Device, by Type USD Million (2019-2024)
  • Table 166. Europe Sleep Aid Device, by Distribution Channel USD Million (2019-2024)
  • Table 167. Europe Sleep Aid Device, by Disorders USD Million (2019-2024)
  • Table 168. Germany Sleep Aid Device, by Type USD Million (2019-2024)
  • Table 169. Germany Sleep Aid Device, by Distribution Channel USD Million (2019-2024)
  • Table 170. Germany Sleep Aid Device, by Disorders USD Million (2019-2024)
  • Table 171. France Sleep Aid Device, by Type USD Million (2019-2024)
  • Table 172. France Sleep Aid Device, by Distribution Channel USD Million (2019-2024)
  • Table 173. France Sleep Aid Device, by Disorders USD Million (2019-2024)
  • Table 174. Italy Sleep Aid Device, by Type USD Million (2019-2024)
  • Table 175. Italy Sleep Aid Device, by Distribution Channel USD Million (2019-2024)
  • Table 176. Italy Sleep Aid Device, by Disorders USD Million (2019-2024)
  • Table 177. United Kingdom Sleep Aid Device, by Type USD Million (2019-2024)
  • Table 178. United Kingdom Sleep Aid Device, by Distribution Channel USD Million (2019-2024)
  • Table 179. United Kingdom Sleep Aid Device, by Disorders USD Million (2019-2024)
  • Table 180. Netherlands Sleep Aid Device, by Type USD Million (2019-2024)
  • Table 181. Netherlands Sleep Aid Device, by Distribution Channel USD Million (2019-2024)
  • Table 182. Netherlands Sleep Aid Device, by Disorders USD Million (2019-2024)
  • Table 183. Rest of Europe Sleep Aid Device, by Type USD Million (2019-2024)
  • Table 184. Rest of Europe Sleep Aid Device, by Distribution Channel USD Million (2019-2024)
  • Table 185. Rest of Europe Sleep Aid Device, by Disorders USD Million (2019-2024)
  • Table 186. MEA Sleep Aid Device, by Country USD Million (2019-2024)
  • Table 187. MEA Sleep Aid Device, by Type USD Million (2019-2024)
  • Table 188. MEA Sleep Aid Device, by Distribution Channel USD Million (2019-2024)
  • Table 189. MEA Sleep Aid Device, by Disorders USD Million (2019-2024)
  • Table 190. Middle East Sleep Aid Device, by Type USD Million (2019-2024)
  • Table 191. Middle East Sleep Aid Device, by Distribution Channel USD Million (2019-2024)
  • Table 192. Middle East Sleep Aid Device, by Disorders USD Million (2019-2024)
  • Table 193. Africa Sleep Aid Device, by Type USD Million (2019-2024)
  • Table 194. Africa Sleep Aid Device, by Distribution Channel USD Million (2019-2024)
  • Table 195. Africa Sleep Aid Device, by Disorders USD Million (2019-2024)
  • Table 196. North America Sleep Aid Device, by Country USD Million (2019-2024)
  • Table 197. North America Sleep Aid Device, by Type USD Million (2019-2024)
  • Table 198. North America Sleep Aid Device, by Distribution Channel USD Million (2019-2024)
  • Table 199. North America Sleep Aid Device, by Disorders USD Million (2019-2024)
  • Table 200. United States Sleep Aid Device, by Type USD Million (2019-2024)
  • Table 201. United States Sleep Aid Device, by Distribution Channel USD Million (2019-2024)
  • Table 202. United States Sleep Aid Device, by Disorders USD Million (2019-2024)
  • Table 203. Canada Sleep Aid Device, by Type USD Million (2019-2024)
  • Table 204. Canada Sleep Aid Device, by Distribution Channel USD Million (2019-2024)
  • Table 205. Canada Sleep Aid Device, by Disorders USD Million (2019-2024)
  • Table 206. Mexico Sleep Aid Device, by Type USD Million (2019-2024)
  • Table 207. Mexico Sleep Aid Device, by Distribution Channel USD Million (2019-2024)
  • Table 208. Mexico Sleep Aid Device, by Disorders USD Million (2019-2024)
  • Table 209. Research Programs/Design for This Report
  • Table 210. Key Data Information from Secondary Sources
  • Table 211. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Sleep Aid Device: by Type USD Million (2013-2018)
  • Figure 5. Global Sleep Aid Device: by Distribution Channel USD Million (2013-2018)
  • Figure 6. Global Sleep Aid Device: by Disorders USD Million (2013-2018)
  • Figure 7. South America Sleep Aid Device Share (%), by Country
  • Figure 8. Asia Pacific Sleep Aid Device Share (%), by Country
  • Figure 9. Europe Sleep Aid Device Share (%), by Country
  • Figure 10. MEA Sleep Aid Device Share (%), by Country
  • Figure 11. North America Sleep Aid Device Share (%), by Country
  • Figure 12. Global Sleep Aid Device share by Players 2018 (%)
  • Figure 13. Global Sleep Aid Device share by Players (Top 3) 2018(%)
  • Figure 14. Global Sleep Aid Device share by Players (Top 5) 2018(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Koninklijke Philips N.V. (Netherlands) Revenue, Net Income and Gross profit
  • Figure 17. Koninklijke Philips N.V. (Netherlands) Revenue: by Geography 2018
  • Figure 18. Merck & Co. (United States) Revenue, Net Income and Gross profit
  • Figure 19. Merck & Co. (United States) Revenue: by Geography 2018
  • Figure 20. Sanofi (France) Revenue, Net Income and Gross profit
  • Figure 21. Sanofi (France) Revenue: by Geography 2018
  • Figure 22. DeVilbiss Healthcare LLC. (United States) Revenue, Net Income and Gross profit
  • Figure 23. DeVilbiss Healthcare LLC. (United States) Revenue: by Geography 2018
  • Figure 24. Pfizer Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 25. Pfizer Inc. (United States) Revenue: by Geography 2018
  • Figure 26. SleepMed Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. SleepMed Inc. (United States) Revenue: by Geography 2018
  • Figure 28. Cadwell Laboratories Inc (United States) Revenue, Net Income and Gross profit
  • Figure 29. Cadwell Laboratories Inc (United States) Revenue: by Geography 2018
  • Figure 30. Compumedics Limited (Australia) Revenue, Net Income and Gross profit
  • Figure 31. Compumedics Limited (Australia) Revenue: by Geography 2018
  • Figure 32. Natus Medical Incorporated (United States) Revenue, Net Income and Gross profit
  • Figure 33. Natus Medical Incorporated (United States) Revenue: by Geography 2018
  • Figure 34. GlaxoSmithKline plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 35. GlaxoSmithKline plc (United Kingdom) Revenue: by Geography 2018
  • Figure 36. Global Sleep Aid Device: by Type USD Million (2013-2018)
  • Figure 37. Global Sleep Aid Device: by Distribution Channel USD Million (2013-2018)
  • Figure 38. Global Sleep Aid Device: by Disorders USD Million (2013-2018)
  • Figure 39. South America Sleep Aid Device Share (%), by Country
  • Figure 40. Asia Pacific Sleep Aid Device Share (%), by Country
  • Figure 41. Europe Sleep Aid Device Share (%), by Country
  • Figure 42. MEA Sleep Aid Device Share (%), by Country
  • Figure 43. North America Sleep Aid Device Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Koninklijke Philips N.V. (Netherlands)
  • Merck & Co. (United States)
  • Sanofi (France)
  • DeVilbiss Healthcare LLC. (United States)
  • Pfizer Inc. (United States)
  • SleepMed Inc. (United States)
  • Cadwell Laboratories Inc (United States)
  • Compumedics Limited (Australia)
  • Natus Medical Incorporated (United States)
  • GlaxoSmithKline plc (United Kingdom)
Additional players considered in the study are as follows:
Teva Pharmaceutical Industries Ltd. (Israel) , Takeda Pharmaceutical Company Limited (Japan) , CareFusion Corporation (United States) , Drive Medical Ltd. (United Kingdom)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation